2024MAY10: Our hosting provider is experiencing intermittent networking issues. We apologize for any inconvenience.

Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Post-transcriptional Regulation of De Novo Lipogenesis by mTORC1-S6K1-SRPK2 Signaling.

Cell | 2017

mTORC1 is a signal integrator and master regulator of cellular anabolic processes linked to cell growth and survival. Here, we demonstrate that mTORC1 promotes lipid biogenesis via SRPK2, a key regulator of RNA-binding SR proteins. mTORC1-activated S6K1 phosphorylates SRPK2 at Ser494, which primes Ser497 phosphorylation by CK1. These phosphorylation events promote SRPK2 nuclear translocation and phosphorylation of SR proteins. Genome-wide transcriptome analysis reveals that lipid biosynthetic enzymes are among the downstream targets of mTORC1-SRPK2 signaling. Mechanistically, SRPK2 promotes SR protein binding to U1-70K to induce splicing of lipogenic pre-mRNAs. Inhibition of this signaling pathway leads to intron retention of lipogenic genes, which triggers nonsense-mediated mRNA decay. Genetic or pharmacological inhibition of SRPK2 blunts de novo lipid synthesis, thereby suppressing cell growth. These results thus reveal a novel role of mTORC1-SRPK2 signaling in post-transcriptional regulation of lipid metabolism and demonstrate that SRPK2 is a potential therapeutic target for mTORC1-driven metabolic disorders.

Pubmed ID: 29153836 RIS Download

Additional research tools detected in this publication

Associated grants

  • Agency: NHLBI NIH HHS, United States
    Id: R01 HL121266
  • Agency: NCI NIH HHS, United States
    Id: R01 CA046595
  • Agency: NHLBI NIH HHS, United States
    Id: R01 HL138481
  • Agency: NIA NIH HHS, United States
    Id: R01 AG054215
  • Agency: NCI NIH HHS, United States
    Id: P01 CA120964
  • Agency: NIDDK NIH HHS, United States
    Id: R01 DK098331
  • Agency: NIGMS NIH HHS, United States
    Id: R01 GM114160
  • Agency: NIDDK NIH HHS, United States
    Id: P30 DK036836
  • Agency: NIGMS NIH HHS, United States
    Id: R01 GM051405
  • Agency: NIGMS NIH HHS, United States
    Id: R01 GM041890
  • Agency: NCI NIH HHS, United States
    Id: R01 CA163591
  • Agency: NCI NIH HHS, United States
    Id: R35 CA197588
  • Agency: NIGMS NIH HHS, United States
    Id: R01 GM062891
  • Agency: NIGMS NIH HHS, United States
    Id: R35 GM122610
  • Agency: NHLBI NIH HHS, United States
    Id: R01 HL098216
  • Agency: NCI NIH HHS, United States
    Id: P30 CA016359

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


New England Biolabs (tool)

RRID:SCR_013517

An Antibody supplier

View all literature mentions

Adobe Photoshop (tool)

RRID:SCR_014199

Software for image processing, analysis, and editing. The software includes features such as touch capabilities, a customizable toolbar, 2D and 3D image merging, and Cloud access and options.

View all literature mentions

Anti-U1-70k (antibody)

RRID:AB_887903

This monoclonal targets U1-70k

View all literature mentions

SREBP-1 (H-160) (antibody)

RRID:AB_2194223

This polyclonal targets SREBF1

View all literature mentions

Lamin A/C (N-18) (antibody)

RRID:AB_648152

This polyclonal targets LMNA

View all literature mentions

GST (Z-5) (antibody)

RRID:AB_631586

This polyclonal targets GST (Z-5)

View all literature mentions

Actin (C-11) (antibody)

RRID:AB_630835

This polyclonal targets ACTG1, ACTC1, ACTA1, ACTA2, ACTG2, ACTB

View all literature mentions

SF2/ASF Antibody (96) (antibody)

RRID:AB_628248

This monoclonal targets SF2/ASF

View all literature mentions

FDFT1 antibody [EPR4626] (antibody)

RRID:AB_10859772

This monoclonal targets FDFT1 antibody [EPR4626]

View all literature mentions

Monoclonal Anti-GAPDH antibody produced in mouse (antibody)

RRID:AB_1078991

This monoclonal targets GAPDH antibody produced in mouse

View all literature mentions

V5-Tag (D3H8Q) Rabbit Antibody (antibody)

RRID:AB_2687461

This monoclonal targets V5-Tag

View all literature mentions

Phospho-p70 S6 Kinase (Thr389) (108D2) Rabbit mAb (antibody)

RRID:AB_2269803

This monoclonal targets p70 S6 Kinase, phospho (Thr389)

View all literature mentions

Phospho-S6 Ribosomal Protein (Ser240/244) (D68F8) XP Rabbit mAb (antibody)

RRID:AB_10694233

This monoclonal targets Phospho-S6 Ribosomal Protein (Ser240/244) (D68F8) XP Rabbit mAb

View all literature mentions

Phospho-S6 Ribosomal Protein (Ser235/236) Antibody (antibody)

RRID:AB_331679

This polyclonal targets Phospho-S6 Ribosomal Protein (Ser235/236)

View all literature mentions

S6 Ribosomal Protein (54D2) Mouse mAb (antibody)

RRID:AB_2238583

This monoclonal targets S6 Ribosomal Protein (54D2) Mouse mAb

View all literature mentions

Fatty Acid Synthase (C20G5) Rabbit mAb (antibody)

RRID:AB_2100796

This monoclonal targets Fatty Acid Synthase

View all literature mentions

ATP-Citrate Lyase Antibody (antibody)

RRID:AB_2223744

This polyclonal targets Acly

View all literature mentions

MAb104 (cell line)

RRID:CVCL_G668

Cell line MAb104 is a Hybridoma with a species of origin Mus musculus

View all literature mentions

DLD-1 (cell line)

RRID:CVCL_0248

Cell line DLD-1 is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions

RT-4 (cell line)

RRID:CVCL_0036

Cell line RT-4 is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions